Hipracox Broilers Yhdistynyt kuningaskunta - englanti - HMA (Heads of Medicines Agencies)

hipracox broilers

laboratorios hipra s. a. - eimeria acervulina 300 iu, eimeria maxima 200 iu, eimeria mitis 300 iu, eimeria praecox 300 iu, eimeria tenella 250 iu - oral suspension - chicken broilers - coccidia vaccine

HIPRACOX BROILERS ORAL SUSPENSION FOR CHICKENS Irlanti - englanti - HPRA (Health Products Regulatory Authority)

hipracox broilers oral suspension for chickens

laboratorios hipra s.a. - eimeria acervulina, strain 003, eimeria maxima, strain 013, eimeria mitis, strain 006, eimeria praecox, strain 007, eimeria tenella, strain 004 - oral suspension - unknown - coccidia vaccine - fowl - chicken - immunological - live vaccine

Hipracox Broilers Oral Suspension for Chickens Yhdistynyt kuningaskunta - englanti - VMD (Veterinary Medicines Directorate)

hipracox broilers oral suspension for chickens

laboratorios hipra sa - eimeria acervulina, eimeria maxima, eimeria mitis, eimeria praecox, eimeria tenella - oral suspension - live parasitic vaccine - chickens

Hipracox Broilers dw Yhdistynyt kuningaskunta - englanti - VMD (Veterinary Medicines Directorate)

hipracox broilers dw

laboratorios hipra sa - eimeria acervulina, eimeria maxima, eimeria mitis, eimeria praecox, eimeria tenella - oral suspension - live parasitic vaccine - chickens

HIPRAGUMBORO-G97 Irlanti - englanti - HPRA (Health Products Regulatory Authority)

hipragumboro-g97

laboratorios hipra s.a. - live infectious bursal disease virus, strain gm97 - lyophilisate for oculonasal suspension/use in drinking water - . - avian infectious bursal disease virus (gumboro disease) - chickens - immunological - live vaccine

Hiprapox Formulation:   Each 0.01 mL of reconstituted vaccine (dose) contains:   Fowl-Pox Virus (FPV92 Strain)................&g Filippiinit - englanti - FDA (Food And Drug Administration)

hiprapox formulation: each 0.01 ml of reconstituted vaccine (dose) contains: fowl-pox virus (fpv92 strain)................&g

n/a; importer: hipra philippines, inc.; distributor: hipra philippines, inc. - live fowl pox (fp) virus vaccine (vet.) - freeze dried tablet for injectable suspension (wing web) - formulation: each 0.01 ml of reconstituted vaccine (dose) contains: fowl-pox virus (fpv92 strain)................>10^4 ei

Hipraspray NOT APPLICABLE Spray Filippiinit - englanti - FDA (Food And Drug Administration)

hipraspray not applicable spray

n/a; importer: hipra philippines, inc.; distributor: hipra philippines, inc. - vaccination device (vet.) - spray - not applicable

Startvac Euroopan unioni - englanti - EMA (European Medicines Agency)

startvac

laboratorios hipra s.a. - escherichia coli j5 inactivated, staphylococcus aureus (cp8) strain sp 140 inactivated, expressing slime-associated antigenic complex - immunologicals for bovidae - cattle (cows and heifers) - for herd immunisation of healthy cows and heifers, in dairy cattle herds with recurring mastitis problems, to reduce the incidence of sub-clinical mastitis and the incidence and the severity of the clinical signs of clinical mastitis caused by staphylococcus aureus, coliforms and coagulase-negative staphylococci.the full immunisation scheme induces immunity from approximately day 13 after the first injection until approximately day 78 after the third injection (equivalent to 130 days post-parturition).

Hiprabovis IBR Marker Live Euroopan unioni - englanti - EMA (European Medicines Agency)

hiprabovis ibr marker live

laboratorios hipra s.a - live ge- tk- double-gene-deleted bovine herpes virus type 1, strain ceddel: 106.3–107.3 ccid50 - immunologicals - cattle - for the active immunisation of cattle from three months of age against bovine herpes virus type 1 (bohv-1) to reduce the clinical signs of infectious bovine rhinotracheitis (ibr) and field virus excretion.onset of immunity: 21 days after completion of the basic vaccination scheme.duration of immunity: 6 months after completion of the basic vaccination scheme

Rhiniseng Euroopan unioni - englanti - EMA (European Medicines Agency)

rhiniseng

laboratorios hipra s.a. - inactivated bordetella bronchiseptica, strain 833cer / recombinant type-d pasteurella-multocida toxin (pmtr) - immunologicals - pigs (gilts and sows) - for the passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with bordetella-bronchiseptica and pasteurella-multocida infections during the fattening period. challenge studies have demonstrated that passive immunity lasts until piglets are six weeks of age while in clinical field trials, the beneficial effects of vaccination (reduction in nasal lesion score and weight loss) are observed until slaughter.